Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Trade Dress Exemption Could Be Short-Term Fix To OTC Label Issues - CTFA

This article was originally published in The Tan Sheet

Executive Summary

A general exemption for OTC products that meet a "clear and conspicuous" performance standard may be an "intermediate fix" for those that do not meet the color requirements in the OTC labeling rule, Cosmetic, Toiletry & Fragrance Association VP-Legal & General Counsel Thomas Donegan suggested. He spoke at an FDA working group meeting to discuss trade dress on product labeling in Rockville, Md. Aug. 24.

You may also be interested in...



OTC Labeling Trade Dress Issues Resolved In FDA Technical Amendment

Labeling of over-the-counter drug products may include light type on a dark background providing the combination results in a highly readable contrast, FDA asserts in a technical amendment to the OTC label final rule published in the Jan. 3 Federal Register.

OTC Labeling Trade Dress Issues Resolved In FDA Technical Amendment

Labeling of over-the-counter drug products may include light type on a dark background providing the combination results in a highly readable contrast, FDA asserts in a technical amendment to the OTC label final rule published in the Jan. 3 Federal Register.

OTC Labeling Trade Dress Issues Resolved In FDA Technical Amendment

Labeling of over-the-counter drug products may include light type on a dark background providing the combination results in a highly readable contrast, FDA asserts in a technical amendment to the OTC label final rule published in the Jan. 3 Federal Register.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090265

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel